Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in AVIDITY BIOSCIENCES INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 188,807 shares of RNA (AVIDITY BIOSCIENCES INC), worth $13.6M as of 2025-Q4. The position was increased (++8.5% shares). RNA represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$13.6M
Current Shares
188,807
Total Value Change
-$693,761
Total Shares Change
-161,558
Other major holders of RNA: VANGUARD GROUP INC, FMR LLC, BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, JANUS HENDERSON GROUP PLC
Increased |
| 188,807 |
+8.5% |
| $13.6M |
| 0.0% |
| $72.15 |
30 |
| 2025-Q3 | Decreased | 173,995 | -56.1% | $7.6M | 0.0% | $42.63 | 0 |
| 2025-Q2 | Increased | 395,965 | +10.7% | $11.2M | 0.0% | $29.03 | 31 |
| 2025-Q1 | Increased | 357,718 | +7.6% | $10.6M | 0.0% | $31.60 | 30 |
| 2024-Q4 | Decreased | 332,389 | -4.7% | $9.7M | 0.0% | $29.18 | 0 |
| 2024-Q3 | Decreased | 348,841 | -0.4% | $16M | 0.0% | $42.33 | 0 |
| 2024-Q2 | Increased | 350,365 | +336.3% | $14.3M | 0.0% | $40.85 | 45 |